Beachbody has achieved eight consecutive quarters of positive adjusted EBITDA with $34 million in cash as of September 30, 2025, exceeding total debt of $25 million. Recent product innovations include the "10 Minute BODi" microdose fitness subscription (launched December 2025) and P90X Generation Next (launched February 2026) with new supplement lines.
Cyborg Score Rationale
The company faces persistent subscriber churn and heightened competition from tech giants that are expected to reduce revenue growth and erode pricing power. With a market capitalization of only $49.35 million and negative profitability metrics, the stock carries significant risk. However, analyst coverage shows mixed sentiment with Craig Hallum initiating a "buy" rating at $15 price target and Canaccord Genuity maintaining a "buy" rating.
Top Insights
Shift to affiliate model and retail expansion broadens market reach and unlocks new revenue opportunities through direct-to-consumer channels.
Fourth-quarter 2025 earnings release scheduled for March 10, 2026 will provide critical insight into turnaround progress.
Credit agreement amendment with Tiger Finance relaxes covenants and streamlines covenant testing to improve financial flexibility.
Company transferred stock listing from NYSE to NASDAQ Capital Market, indicating continued public market navigation challenges.